Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hospice × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 100 Carcinoma, Non-Small-Cell Lung 85 Prostatic Neoplasms 80 Multiple Myeloma 62 Leukemia, Myeloid, Acute 56 Neoplasms 50 Colorectal Neoplasms 47 Lung Neoplasms 44 Neoplasm Metastasis 38 Squamous Cell Carcinoma of Head and Neck 37 Melanoma 36 Triple Negative Breast Neoplasms 34 Ovarian Neoplasms 34 Pancreatic Neoplasms 33 Lymphoma 33 Brain Neoplasms 32 Carcinoma, Hepatocellular 31 Carcinoma, Renal Cell 29 Urinary Bladder Neoplasms 27 Recurrence 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Sarcoma 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Lymphoma, Follicular 22 Glioblastoma 22 Stomach Neoplasms 21 Hematologic Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 20 Glioma 20 Uterine Cervical Neoplasms 19

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡